Omnipaque 140mg/ml Inj, 50ml
Overview
What is this medicine?
How to Use This Medicine
To ensure safe and effective use of this medication, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the guidelines outlined below.
Preparation and Administration
Before receiving this medication, it is essential to be properly hydrated. Consult your doctor to determine if you need to drink additional fluids before administration. After taking this medication, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Administration Methods
Injection: Your doctor will administer this medication. You may receive other medications before this one to help minimize side effects.
Liquid: This medication can be taken orally or administered rectally.
Storage and Disposal
Liquid: If you need to store this medication at home, consult your doctor, nurse, or pharmacist for guidance on proper storage.
Injection: This medication will be administered in a healthcare setting, and you will not need to store it at home.
Missed Dose
Liquid: If you miss a dose, contact your doctor to determine the best course of action.
Injection: Since this medication is administered in a healthcare setting, you will not need to worry about missing a dose.
Lifestyle & Tips
- Stay well-hydrated before and after the procedure, especially if you have kidney problems.
- Inform your doctor about all your medications, especially metformin, and any allergies, particularly to iodine or previous contrast dyes.
- Follow all instructions regarding fasting or medication adjustments before the procedure.
Available Forms & Alternatives
Available Strengths:
- Omnipaque 300mg/ml Inj, 30ml
- Omnipaque 240mg/ml Inj, 50ml
- Omnipaque 350mg/ml Inj, 50ml
- Omnipaque 240mg/ml Inj, 100ml
- Omnipaque 350mg/ml Inj, 500ml
- Omnipaque 300mg/ml Inj, 50ml
- Omnipaque 180mg/ml Inj, 10ml
- Omnipaque 350mg/ml Inj, 200ml
- Omnipaque 350mg/ml Inj, 150ml
- Omnipaque 350mg/ml Inj, 100ml
- Omnipaque 240mg/ml Inj, 20ml
- Omnipaque 240mg/ml Inj, 10ml
- Omnipaque 300mg/ml Inj, 150ml
- Omnipaque 300mg/ml Inj, 100ml
- Omnipaque 300mg/ml Inj, 500ml
- Omnipaque 300mg/ml Inj, 10ml
- Omnipaque 140mg/ml Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Allergic Reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be fatal.
Thyroid Problems: Changes in weight, feeling nervous, excitable, restless, or weak, hair thinning, depression, eye or neck swelling, difficulty focusing, trouble with heat or cold, menstrual changes, shakiness, or sweating.
Injection-Related Side Effects:
+ Chest pain or pressure, rapid heartbeat, or abnormal heartbeat.
+ Weakness on one side of the body, trouble speaking or thinking, changes in balance, drooping on one side of the face, or blurred vision.
+ Severe dizziness or fainting.
+ Shortness of breath, significant weight gain, or swelling in the arms or legs.
+ Swelling, warmth, numbness, color changes, or pain in a leg or arm.
+ Seizures.
+ Changes in vision.
Tissue Damage: If the medication leaks from the vein, it can cause tissue damage. Inform your nurse if you experience redness, burning, pain, swelling, blisters, skin sores, or fluid leakage at the injection site.
Severe Skin Reactions: These can occur anywhere from 1 hour to several weeks after receiving the medication and may include:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening.
+ Symptoms may include red, swollen, blistered, or peeling skin; red or irritated eyes; sores in the mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands. Seek medical help immediately if you experience any of these symptoms.
Spinal Injection Side Effects: A burning, numbness, or tingling sensation that is not normal.
Liquid Form Side Effects: Swelling.
Other Possible Side Effects
Most people do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:
Common Side Effects:
+ Upset stomach or vomiting
+ Headache
Injection-Related Side Effects:
+ Dizziness (if given in an artery or vein)
+ Feeling of warmth
+ Changes in taste
+ Dizziness (if given into the spine)
+ Back pain
+ Neck pain
+ Stiff neck
Liquid Form Side Effects:
+ Stomach pain or diarrhea
+ Gas
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Difficulty breathing or wheezing
- Hives, rash, or severe itching
- Swelling of your face, lips, tongue, or throat
- Sudden dizziness or feeling faint
- Chest pain or tightness
- Unusual weakness or fatigue
- Changes in urination (less frequent or no urination)
Before Using This Medicine
It is essential to inform your doctor about the following conditions before starting this medication:
Any allergies you have, including allergies to this drug, its components, or other substances, and describe the symptoms you experienced.
If you are dehydrated, have been eating poorly, or have recently used a laxative or diuretic.
If you have had a skin reaction to this medication or a similar drug in the past.
If you are taking metformin.
Additional Considerations for Specific Administration Routes:
If you will be receiving this medication via spinal injection:
+ Inform your doctor if you have an active infection.
+ Disclose any medications you are taking that may increase the risk of seizures or if you have taken such a medication within the last 48 hours. Your doctor or pharmacist can help you identify these medications.
If you will be receiving this medication via injection into an artery or vein:
+ Tell your doctor if you are unable to urinate.
* If this medication will be used before an x-ray of the uterus and fallopian tubes:
+ Inform your doctor if you are currently menstruating, have a genital infection, or have a known or suspected growth in the reproductive tract.
+ Share your history if you have had a curettage or conization procedure within the past 30 days.
+ Inform your doctor if you have had a pregnancy terminated within the past 6 months.
+ Do not take this medication if you are pregnant or suspect you may be pregnant.
Interactions with Other Medications and Health Conditions:
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. Ensure it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may need to monitor your blood work, and this medication may affect certain lab tests. Be sure to notify all your healthcare providers and lab workers that you are taking this drug.
If you experience any signs of kidney problems, such as difficulty urinating, changes in urine output, bloody, brown, or foamy urine, shortness of breath, cough, or swelling in your face, feet, or hands, contact your doctor immediately.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Similarly, if the patient is a child, this medication should be used with caution, as the risk of side effects may be higher in some children.
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the potential benefits and risks to you and your baby.
Injection (Given in an Artery or Vein)
In children under 3 years of age, the use of medications like this one has been associated with low thyroid function, which can impact child development. If the patient is a child, your doctor may recommend monitoring their thyroid function for a period after the injection. If you have questions or concerns, consult your doctor.
Rarely, life-threatening or fatal heart problems, including low blood pressure and heart attack, have been reported with this medication. Discuss these risks with your doctor.
Additionally, health problems like blood clots have occurred with this medication when used in conjunction with certain procedures. In some cases, blood clots can lead to heart attack and stroke, which can be fatal. If you have questions, consult your doctor.
Injection (Given into the Spine)
This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.
Overdose Information
Overdose Symptoms:
- Severe hypotension
- Bradycardia
- Cyanosis
- Lactic acidosis
- Seizures
- Coma
- Acute renal failure
What to Do:
Treatment is supportive. Maintain vital functions. Iohexol is dialyzable. In case of suspected overdose, immediately seek emergency medical attention or call a poison control center (e.g., 1-800-222-1222 in the US).
Drug Interactions
Major Interactions
- Metformin (in patients with renal impairment or acute kidney injury): Risk of lactic acidosis. Metformin should be withheld at the time of or prior to the procedure and for 48 hours after, and reinstituted only after renal function has been re-evaluated and found to be normal.
- Interleukin-2 (IL-2) therapy: Increased risk of delayed adverse reactions (e.g., fever, flu-like symptoms, rash, oliguria, renal failure) due to potential for enhanced contrast retention.
Moderate Interactions
- Beta-blockers: Increased risk of anaphylactoid reactions and reduced efficacy of epinephrine in treating severe reactions.
- Diuretics: May increase risk of contrast-induced nephropathy due to dehydration.
- Nephrotoxic drugs (e.g., NSAIDs, aminoglycosides, cisplatin): Concomitant use may increase risk of contrast-induced nephropathy.
- Oral cholecystographic agents: May interfere with visualization if administered prior to iohexol.
Confidence Interactions
Monitoring
Baseline Monitoring
Rationale: To assess baseline kidney function and risk of contrast-induced nephropathy (CIN).
Timing: Prior to contrast administration, especially in patients with risk factors for CIN.
Rationale: To identify patients at increased risk for hypersensitivity reactions.
Timing: Prior to contrast administration.
Rationale: To assess risk of contrast-induced hyperthyroidism or thyrotoxic crisis, especially in patients with pre-existing thyroid disease.
Timing: Prior to contrast administration in high-risk patients.
Rationale: Dehydration increases risk of CIN.
Timing: Prior to contrast administration.
Routine Monitoring
Frequency: Before, during, and immediately after injection, then as clinically indicated.
Target: Within patient's normal limits.
Action Threshold: Significant deviations, signs of allergic reaction or hemodynamic instability.
Frequency: Continuously during and for at least 30 minutes post-injection.
Target: Absence of symptoms.
Action Threshold: Rash, urticaria, pruritus, dyspnea, bronchospasm, angioedema, hypotension.
Frequency: 48-72 hours post-contrast in high-risk patients (e.g., pre-existing renal impairment, diabetes, heart failure, elderly).
Target: Return to baseline or within acceptable limits.
Action Threshold: Increase in serum creatinine by âĨ 0.3 mg/dL or âĨ 50% from baseline within 48-72 hours.
Symptom Monitoring
- Hives
- Itching
- Rash
- Swelling of face/throat/tongue
- Difficulty breathing
- Wheezing
- Lightheadedness
- Dizziness
- Nausea
- Vomiting
- Headache
- Warm sensation
- Metallic taste
- Chest pain
- Shortness of breath
- Flushing
- Chills
- Fever
- Pain or discomfort at injection site
Special Patient Groups
Pregnancy
Category B. Animal studies have not shown fetal harm. Limited human data suggest low risk. Use only if clearly needed and potential benefits outweigh risks. Consider non-iodinated alternatives if available and appropriate.
Trimester-Specific Risks:
Lactation
L2 (Safer). Iohexol is minimally excreted into breast milk and poorly absorbed by the infant's GI tract. Infant exposure is very low. Breastfeeding can generally continue without interruption. If concerns exist, a temporary interruption (e.g., 12-24 hours) and discarding milk may be considered, but is often not necessary.
Pediatric Use
Dosing is weight-based and procedure-specific. Children, especially neonates and infants, are more susceptible to fluid shifts and temperature changes. Careful attention to hydration and temperature regulation is crucial. Renal function should be assessed. Risk of contrast-induced nephropathy is generally lower than in adults but still a consideration in vulnerable populations.
Geriatric Use
Increased risk of contrast-induced nephropathy due to age-related decline in renal function, comorbidities (e.g., diabetes, heart failure), and polypharmacy. Careful assessment of renal function and hydration status is essential. Use lowest effective dose and ensure adequate pre- and post-hydration.
Clinical Information
Clinical Pearls
- Always assess renal function (CrCl or eGFR) before administering iohexol, especially in high-risk patients.
- Ensure adequate hydration before and after contrast administration to minimize the risk of contrast-induced nephropathy (CIN).
- Patients on metformin should have it withheld before and for 48 hours after contrast administration, with renal function re-evaluated before restarting.
- Be prepared for hypersensitivity reactions, ranging from mild to severe anaphylaxis. Have resuscitation equipment and medications readily available.
- Nonionic contrast agents like iohexol generally have a lower incidence of adverse reactions compared to ionic agents.
- For intrathecal use, ensure the correct concentration and volume are used, as higher concentrations or volumes can lead to neurotoxicity.
Alternative Therapies
- Other iodinated contrast media (e.g., Ioversol, Iopamidol, Iodixanol)
- Gadolinium-based contrast agents (for MRI, different mechanism)
- Ultrasound with contrast (e.g., microbubble agents)
- Non-contrast imaging modalities (e.g., plain X-ray, non-contrast CT, MRI, ultrasound)